Virica Biotech is excited to welcome Dr. James Taylor, co-founder and former CEO of Precision NanoSystems, to our Board of Directors!
James transformed PNI into a global leader in lipid-nanoparticle and mRNA-based genetic-medicine platforms, guiding its acquisition by Danaher and integration into Cytiva’s Life Sciences portfolio. With deep expertise in microfluidics, nanotechnology, and scaling advanced therapeutics, plus prior board experience with Life Sciences BC, James brings unmatched strategic insight to Virica.
“James’ track record of translating cutting-edge science into commercially viable platforms aligns perfectly with Virica’s mission to accelerate viral-vector manufacturing. His strategic vision and operator’s mindset will be invaluable as we expand our VSE™ technology globally.” — Jean-Simon Diallo, Ph.D., CEO, Virica Biotech
Read the full press release here.